DeepMed Research

MALLINCKRODT UK FINANCE LLP

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients

Phase 3

Completed

Conditions: Acute Pain

Interventions: Drug: IV Acetaminophen
Drug: IV Control

First Posted Date: 2012-07-06

Last Posted Date: 2020-01-21

Lead Sponsor: Mallinckrodt

Target Recruit Count: 197

Registration Number: NCT01635101

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Amplatz Children's Hospital, Minneapolis, Minnesota, United States
🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

and more 19 locations

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients

Phase 2

Completed

Conditions: Diabetic Nephropathy

Interventions: Drug: Repository Corticotropin Injection
Drug: Placebo

First Posted Date: 2012-05-17

Last Posted Date: 2019-11-18

Lead Sponsor: Mallinckrodt

Target Recruit Count: 34

Registration Number: NCT01601236

Locations: 🇺🇸
Questcor Investigational Site, San Antonio, Texas, United States

Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis

Conditions: Osteoarthritis of the Hand

First Posted Date: 2012-04-18

Last Posted Date: 2012-04-19

Lead Sponsor: Mallinckrodt

Registration Number: NCT01579890

Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire

Completed

Conditions: Multiple Sclerosis

Interventions: Other: ARMS Questionnaire

First Posted Date: 2012-03-07

Last Posted Date: 2016-10-19

Lead Sponsor: Mallinckrodt

Target Recruit Count: 103

Registration Number: NCT01547351

Locations: 🇺🇸
Tanner Center and Foundation for MS, Birmingham, Alabama, United States
🇺🇸
Neurology Center, Oceanside, California, United States
🇺🇸
Neurology Center of Fairfax, Fairfax, Virginia, United States

and more 2 locations

A Study of Fibrocaps™ in Surgical Bleeding

Phase 3

Completed

Conditions: Mild or Moderate Surgical Bleeding

Interventions: Biological: Gelatin sponge
Biological: Fibrocaps

First Posted Date: 2012-02-07

Last Posted Date: 2019-12-18

Lead Sponsor: Mallinckrodt

Target Recruit Count: 721

Registration Number: NCT01527357

Locations: 🇺🇸
University of Southern California, Keck School of Medicine, Los Angeles, California, United States
🇺🇸
Virginia Mason Medical Center, Seattle, Washington, United States
🇺🇸
University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, United States

and more 45 locations

Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension

Phase 3

Completed

Conditions: Pain, Postoperative
Bunion

Interventions: Drug: COV795
Drug: Placebo

First Posted Date: 2011-12-02

Last Posted Date: 2016-10-21

Lead Sponsor: Mallinckrodt

Target Recruit Count: 329

Registration Number: NCT01484652

Locations: 🇺🇸
Trovare Clinical Research, Inc., Bakersfield, California, United States
🇺🇸
Lotus Clinical Research, LLC, Pasedena, California, United States
🇺🇸
Chesapeake Research Group, LLC, Pasadena, Maryland, United States

and more 2 locations

Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain

Phase 3

Completed

Conditions: Low Back Pain
Osteoarthritis

Interventions: Drug: COV795

First Posted Date: 2011-10-13

Last Posted Date: 2020-09-18

Lead Sponsor: Mallinckrodt

Target Recruit Count: 376

Registration Number: NCT01451385

Locations: 🇺🇸
Associated Pharmaceutical Research Center, Inc., Buena Park, California, United States
🇺🇸
Catalina Research Institute, LLC, Chino, California, United States
🇺🇸
Synergy Escondido Clinical Research, Escondido, California, United States

and more 38 locations

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

Phase 4

Completed

Conditions: Idiopathic Membranous Nephropathy
Proteinuria

Interventions: Drug: Repository Corticotropin Injection
Drug: Placebo

First Posted Date: 2011-07-01

Last Posted Date: 2019-11-20

Lead Sponsor: Mallinckrodt

Target Recruit Count: 60

Registration Number: NCT01386554

Locations: 🇲🇽
Mallinckrodt Investigational Site, San Nicolas de los Garza, Nuevo Leon, Mexico
🇹🇷
Mallinckrodt Investigational Site 307, Adana, Turkey
🇹🇷
Mallinckrodt Investigational Site 301, Istanbul, Turkey

and more 7 locations

Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)

Early Phase 1

Completed

Conditions: Chronic Graft Versus Host Disease

Interventions: Drug: ECP Methoxsalen
Drug: Standard of Care

First Posted Date: 2011-06-27

Last Posted Date: 2020-02-19

Lead Sponsor: Mallinckrodt

Target Recruit Count: 60

Registration Number: NCT01380535

Locations: 🇺🇸
Medical City Dallas Hospital,Transplant center, Dallas, Texas, United States
🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States
🇮🇹
A.O.U. Policlinico- Vittorio Emanuele, Catania, Italy

and more 29 locations

U.S. Study of Fibrocaps in Surgical Hemostasis

Not Applicable

Completed

Conditions: Postoperative Hemorrhage

Interventions: Device: Gelfoam
Device: Fibrocaps (fibrin sealant)

First Posted Date: 2010-12-08

Last Posted Date: 2017-09-13

Lead Sponsor: Mallinckrodt

Target Recruit Count: 70

Registration Number: NCT01256164

Locations: 🇺🇸
Various sites, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy